Cytokines and immunodeficiency diseases

@article{Leonard2001CytokinesAI,
  title={Cytokines and immunodeficiency diseases},
  author={Warren J. Leonard},
  journal={Nature Reviews Immunology},
  year={2001},
  volume={1},
  pages={200-208}
}
  • W. Leonard
  • Published 1 December 2001
  • Biology, Medicine
  • Nature Reviews Immunology
Severe combined immunodeficiency disease (SCID) refers to a spectrum of inherited immunodeficiencies that together represent the most severe forms of primary immunodeficiency in humans. Recent work has shown that many of these diseases, as well as other forms of immunodeficiency, result from defects in cytokine signalling pathways. Such defects can prevent normal development of lymphoid lineages and/or compromise cytokine signalling by these cells. These natural 'experiments' in human genetics… 
Immune deficiencies due to defects in cytokine signaling
TLDR
The identification of the genetic defects in humans with SCID provides the basis for future therapies for these patients and insight into the underlying signaling defects in inherited immunodeficiencies is provided.
Severe Combined Immunodeficiency as Diseases of Defective Cytokine Signaling
TLDR
The knowledge of the causes of these diseases has elucidated basic mechanisms of human immunology which have provided insight into the molecular basis of these complex diseases.
Human primary immunodeficiency diseases.
TLDR
Understanding the molecular pathophysiology of PID is not only contributing to a better knowledge of the immune system but may also favor new therapeutic approaches.
Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution.
  • R. Buckley
  • Biology, Medicine
    Annual review of immunology
  • 2004
TLDR
Mutations in nine different genes have been found to cause the human severe combined immunodeficiency syndrome, resulting in a near absence of circulating mature CD3+ T cells and a complete lack of gamma/delta T cells.
Severe combined immunodeficiency. A model disease for molecular immunology and therapy
TLDR
Based on the assumption that long‐lasting pluripotent progenitor cells are transduced, these data suggest that gene therapy could overcome the long‐term recurrence of the T‐cell immunodeficiency.
Severe Combined Immune Deficiency (SCID): Genetics
TLDR
Severe combined immunodeficiency consists of an array of genetically determined blocks in T-lymphocyte development that affect multiple steps of T lymphocytes ontogenesis, and SCID variants – defined by the presence of residual T cells – are relatively frequent as a consequence of hypomorphic mutation or reversion.
Severe combined immunodeficiency pig as an emerging animal model for human diseases and regenerative medicines
TLDR
Underlying mechanisms of human SCID, recent progress in the development of SCID animal models, and utilization ofSCID pig model in biomedical sciences are focused on.
Generation and characterization of severe combined immunodeficiency rats.
TLDR
Xenotransplantation of human induced pluripotent stem cells, ovarian cancer cells, and hepatocytes shows that SCID and FSG rats can act as hosts for xenogeneic tissue grafts and stem cell transplantation and may be useful for preclinical testing of new drugs.
Clinical and Genetic Perspectives in Primary Immunodeficiency Disorders
TLDR
This chapter talks about molecular basis of congenital Immunodeficiencies; immune consequences of defects in hematopoiesis and clinical features of various immunodeficient states, as well as the relationship between specific immune defects, opportunistic pathogens, and clinical syndromes.
Interleukin-7 deficiency in rheumatoid arthritis
  • W. Leonard
  • Medicine
    Arthritis research & therapy
  • 2005
TLDR
A finding that relates not only to the T-lymphocyte status in this disease but also to the ability of patients with rheumatoid arthritis to recover from therapy-induced lymphopenia is found.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 122 REFERENCES
Recombinant interleukin 2 therapy in severe combined immunodeficiency disease.
  • R. Pahwa, T. Chatila, +7 authors R. Good
  • Biology, Medicine
    Proceedings of the National Academy of Sciences of the United States of America
  • 1989
TLDR
A female child with SCID who had a primary defect in the ability of T cells to secrete interleukin 2 (IL-2) is described, pointing to a new direction in the treatment of such disorders with r IL-2.
Severe combined immunodeficiency due to a specific defect in the production of interleukin-2.
TLDR
Together, the X-linked and adenosine deaminase—deficient forms of SCID account for approximately 40 to 50 percent of all cases.
Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease.
TLDR
A gene therapy trial for SCID-X1 was initiated, based on the use of complementary DNA containing a defective gammac Moloney retrovirus-derived vector and ex vivo infection of CD34+ cells, which provided full correction of disease phenotype and clinical benefit.
Defective IL7R expression in T-B+NK + severe combined immunodeficiency
TLDR
It is demonstrated that defective IL7R expression causes T–B +NK+ SCID, indicating that the T- cell, but not the NK-cell, defect in XSCID results from inactivation of IL-7Rα signalling.
Restoration of lymphoid populations in a murine model of X-linked severe combined immunodeficiency by a gene-therapy approach.
TLDR
Transfer of the human gamma(c) gene to repopulating hematopoietic stem cells using an ecotropic retrovirus resulted in an increase in T cells, B cells, natural killer cells, and intestinal intraepithelial lymphocytes, as well as normalization of the CD4:CD8 T-cell ratio and of serum Ig levels.
Mutations in the gene for the IL-7 receptor result in T(-)B(+)NK(+) severe combined immunodeficiency disease.
TLDR
A major role for IL-7-receptor-dependent signaling in T cell development in humans is established and probably explains the diminished T cell numbers seen in patients with X-linked SCID or SCID that results from Jak3-deficiency.
The molecular basis of X-linked severe combined immunodeficiency: defective cytokine receptor signaling.
  • W. Leonard
  • Biology, Medicine
    Annual review of medicine
  • 1996
TLDR
The fact that the phenotype and clinical manifestations in XSCID are more severe than the abnormalities found in humans or mice deficient inIL-2 led to the speculation and subsequent confirmation that the IL-2 receptor is not the only receptor to contain the gamma chain, gamma c, and the role of gamma c in signaling and lymphoid development and the implications of a shared receptor component are discussed.
Defective Lymphoid Development in Mice Lacking Jak3
TLDR
Jak3 plays a critical role in γc signaling and lymphoid development in thymocytes and severe B cell and T cell lymphopenia similar to severe combined immunodeficiency disease (SCID).
Human immune disorder arising from mutation of the α chain of the interleukin-2 receptor
TLDR
A novel human immune aberration arising from a truncation mutation of the interleukin-2 receptor α chain (CD25), a subunit of the tripartite high-affinity receptor for interleuxin 2, is described here by decreased numbers of peripheral T cells displaying abnormal proliferation but normal B cell development.
Human IL-2 Receptor α Chain Deficiency
TLDR
A novel human immune aberration arising from a truncation mutation of the IL-2 receptor α chain (CD25), a subunit of the tripartite high-affinity receptor for IL-1, is described, resulting in expansion of autoreactive clones in multiple tissues.
...
1
2
3
4
5
...